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ABSTRACT
Background and Objectives: We sought to provide in-
formed recommendations on transitioning from laparo-
scopic radical prostatectomy (LRP) to robotic-assisted rad-
ical prostatectomy (RAP) through a study of the da Vinci
robot.
Methods: We performed a cost-benefit analysis to deter-
mine the impact that purchasing a $1.5 million da Vinci
robot with a $112,000 service contract per year and $200
per case of disposables would have on profits of a mature
laparoscopic prostatectomy program.
Results: Seventy-eight cases per year are needed to cover
the costs of a purchased robot, while only 20 cases per
year are needed if a robot is donated. Once robot costs are
covered, increases in caseload lead to increased income.
Profit is not feasible at centers performing fewer than 25
cases annually. A donated robot lessens costs and allows
reasonable revenue without drastic increases in caseload.
Conclusions: Our data suggest a high-volume LRP pro-
gram can convert to RAP and maintain profits; however,
the cost of the robot precludes equal income as that with
LRP. Purchasing a robot is not fiscally viable in a low-
volume program. Given comparable outcomes between
LRP and RAP, hospitals need to decide whether market
forces or the intangible benefits of robotics outweigh the
expenses of obtaining and operating a robot.
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INTRODUCTION
First described in 2001,1,2 robotic-assisted radical prosta-
tectomy (RAP) now constitutes a substantial portion of the
minimally invasive prostatectomy market, as 2 new hos-
pitals acquire a da Vinci robot per week (Intuitive Surgi-
cal, personal communication October 2006). The benefits
associated with transitioning from open radical retropubic
prostatectomy (RRP) to either RAP or laparoscopic radical
prostatectomy (LRP) have been well described: shorter
length of stay and less blood loss.3–8 Overall, though, the
outcomes of LRP and RAP are equivalent, and most ma-
ture series report blood loss of 200 mL to 300 mL per case
with a 1 day to 2 day length of stay.9–11
Many centers adopt RAP because of the ease with which
surgeons can transition from open surgery using the da
Vinci robot, thereby rapidly realizing the aforementioned
benefits of minimally invasive surgery; however, a mature
LRP program already enjoys these improved outcomes.
Faced with possible erosion of their market share to RAP
programs, institutions and surgeons performing LRP must
decide whether they should adopt an expensive technol-
ogy without necessarily improving their results.
Lotan et al9 demonstrate that RRP is more cost effective
than LRP and substantially more cost effective than RAP,
and Scales et al10 show that RAP only becomes cost effec-
tive in specific markets and at surgical volumes that are
not feasible for most centers. On the other hand, little data
exist on the economics of converting from LRP to RAP,
and thus there is little information to guide an LRP pro-
gram as to whether it should purchase a da Vinci robot.
We performed a cost benefit analysis of obtaining a da
Vinci robot at a mature LRP program to offer informed
recommendations on transitioning from LRP to RAP.
METHODS
A cost-benefit analysis was performed using single-insti-
tutional data on caseload, operative times, and profits for
LRP. The cost of the da Vinci robot was obtained from
Intuitive Surgical. This analysis utilized the $1.5 million da
Vinci-S robot. The cost of the robot was amortized over 5
years; thus, the robot costs $300,000 per year and the
service contract is $112,000 per year. The cost of dispos-
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SCIENTIFIC PAPERables is $200 per case, more than current practice at our
institution.
A profit of $5,409 per case was utilized in the analysis, and
multiplying this by annual case volume yields total annual
profit. The total annual profits less costs of the da Vinci
robot equals the annual profitability of RAP. Variable an-
nual case volume of 25 to 250 cases per year was utilized
in our model. Calculations were also made if the robot
was donated, whereby the institution pays for disposable
equipment and the service contract, but not the da Vinci
robot.9 The primary outcome was profit per case in 2005
dollars.
This model excludes the learning curve for RAP. After the
learning curve, it was assumed that LRP and RAP would
take the same amount of operating time and thus the
operating room and anesthesia-associated costs to per-
form RAP are identical to the current practice of LRP.
Considering no distinct CPT code exists for RAP, reim-
bursement was considered equal between LRP and RAP.
Furthermore, length of stay (LOS), blood loss, operative
time, room turnover time, and all oncologic outcomes
were considered equivalent between LRP and RAP. The
associated costs of resident involvement in these cases
were not assessed. Cost-benefit analysis was performed
using Microsoft Excel 2003.
RESULTS
Purchase of a robot reduces income by at least $415,000
per year, due to the cost of the device and the service
contract. Donation of a robot lessens the financial impact
by $300,000 per year. If an institution maintains an iden-
tical caseload when switching from LRP to RAP, then it
cannot maintain equivalent profits as illustrated in Figure
1. This holds true even if the robot is donated.
To maintain profits, an increase in caseload is needed to
cover the added costs of the robot. Figure 2 shows the
annual caseload, compared with baseline case volume,
needed to maintain profitability if a robot is purchased.
The equivalent data for donation of a robot is shown in
Figure 3. At all levels of baseline productivity, purchase
of a robot requires a greater case volume to maintain
profits, relative to donation of a robot. Centers that per-
form a high volume of LRP at baseline need to only make
small increases in total case volume to maintain profit,
while centers with low volumes at baseline need to make
very large changes in operative volume to cover the ad-
ditional costs of robotics.
DISCUSSION
Robotic surgery allows novice laparoscopic surgeons to
rapidly incorporate minimally invasive surgery into their
armamentarium, and urologists have been leaders in this
movement. Robotic surgery is associated with more intu-
itive instruments and operative skills than laparoscopy is;
however, this comes with a price tag in excess of $1
million just for an operative robot. Patient demand has
fueled the explosion of RAP in the last 5 years, while
convincing evidence that RAP leads to outcomes that are
superior to LRP outcomes is absent. Concurrently, LRP has
not blossomed and constitutes a small percentage of the
overall prostatectomy market in the United States.
Other authors have investigated the economics of con-
verting to LRP or RAP from open surgery and in that
comparison a shorter LOS, less blood loss, and fewer
transfusions are critical benefits of the minimally invasive
approach.10,11 In our analysis, we consider a mature LRP
program, where these benefits are incurred costs that
cannot be recovered, and whether adopting robotic
technology makes financial sense for such a program. The
decisive factor for a mature LRP program will likely in-
volve market share relative to rival institutions that offer
RAP, as opposed to the true benefit of RAP over LRP.
Like an airline making money with an airplane, the robot
will only pay for itself if it is used at a high volume. This
distinction is profound if an institution is fiscally respon-
sible for the entire cost of the robot and even more
pronounced in a low volume center. A center loses money
until it performs 78 RAP per year, at which point the robot
and its service contract are paid for. The impact of this
relationship cannot be understated, considering 85% of
Figure 1. Annual Profit of laparoscopic radical prostatectomy as
a function of caseload.
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year,12 and only 7% of all hospitals are high-volume pros-
tatectomy centers, performing over 54 prostatectomies per
year.13 Thus, a low-volume prostatectomy center may not
overcome the learning curve for RAP rapidly, taking 1 or
even 2 years to master the technique. In a geographic
region with a small population base, such as ours, there
may not be a sufficient number of patients with localized
prostate cancer who are even eligible for RAP to make up
the difference in caseload needed to maintain profits.
With such economic pressures clearly involved in conver-
sion to RAP, there are significant ramifications for provid-
ers and patients.
Our analysis has several limitations. Foremost, we utilized
data from a single institution, and we used average profit
per case as our financial outcome. We did not use costs in
our analysis, and rather subtracted the expense of the
robot from existing profits, as the additional costs of the
robot would be paid for by the current profits from LRP.
We did not use charges, as these vary as to who is paying
the bill and are subject to wide local variation.
Figure 2. Annual Caseload to Maintain Profits with Purchase of Robot
Figure 3. Annual Caseload to Maintain Profits with Donation of Robot
JSLS (2008)12:9–12 11We did not stratify our results based on specific OR time
as others have, and rather used total annual case volume
as our benchmark. Although OR time is costly, and there
will be variation in operative time between LRP and RAP,
published results suggest this is a small difference when
an LRP program converts to RAP.14,15
Exclusion of the learning curve from our analysis is also a
limitation. Not only is the surgeon learning curve an im-
portant aspect of adopting a new technology, the operat-
ing team adapting to robotics entails costs. Removing
these costs from our analysis makes RAP appear more
profitable than it really is. Though the learning curve is a
short-lived phenomenon at a high-volume center, it may
take several months or even years at a low-volume center,
where the costs may be substantial.16
Finally, we did not consider the impact that residents or
fellows have on costs. Data illustrating the effect of resi-
dents and fellows on operative times and on the learning
curve for RAP are lacking in the literature, and our data
may be most applicable to a setting where trainees are not
an integral part of such cases.
CONCLUSION
Our data suggest that a high volume LRP program can
convert to RAP and maintain reasonable profits; how-
ever, equal profit with LRP is not possible without a
dramatic increase in caseload. Certainly if a moderate-
to high-volume program maintains its caseload after
obtaining a robot then it will still be profitable, although
less so than before adopting RAP. Given comparable
outcomes between LRP and RAP, hospitals need to
decide whether market forces or the intangible benefits
of robotics outweigh the expenses of obtaining and
operating a robot.
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